Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo

Nature Medicine

Volumn 17, Issue 12, 2011, Pages 1680-1684

  Yoo, Hongki ^a   Kim, Jin Won ^a,b   Shishkov, Milen ^a   Namati, Eman ^a   Morse, Theodore ^c   Shubochkin, Roman ^c   McCarthy, Jason R ^a   Ntziachristos, Vasilis ^d   Bouma, Brett E ^a,e   Jaffer, Farouc A ^a   Tearney, Guillermo J ^a,e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Korea University College of Medicine   (South Korea)

^c BOSTON UNIVERSITY   (United States)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTERY CATHETERIZATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; INFLAMMATION; MOLECULAR IMAGING; NEAR INFRARED FLUORESCENCE; NONHUMAN; OPTICAL FREQUENCY DOMAIN IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; STENT; STENT THROMBOSIS; TISSUE STRUCTURE;

ANIMALS; ARTERIES; CATHETERS; CORONARY ARTERY DISEASE; HUMANS; INFLAMMATION; MOLECULAR IMAGING; MYOCARDIAL INFARCTION; PLAQUE, ATHEROSCLEROTIC; RABBITS; SPECTROSCOPY, NEAR-INFRARED;

EID: 84856119961     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2555     Document Type: Article

References (26)

1. Lloyd-Jones D. et al. Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119, 480-486 (2009).
2. Yun S.H. et al. Comprehensive volumetric optical microscopy in vivo. Nat. Med. 12, 1429-1433 (2006). (Pubitemid 44924503)
3. Huang D. et al. Optical coherence tomography. Science 254, 1178-1181 (1991). (Pubitemid 21917444)
4. Choma M., Sarunic M., Yang C. & Izatt J. Sensitivity advantage of swept source and Fourier domain optical coherence tomography. Opt. Express 11, 2183-2189 (2003).
5. Hausler G. & Lindner M.W. "Coherence Radar" and "Spectral Radar"-new tools for dermatological diagnosis. J. Biomed. Opt. 3, 21-31 (1998). (Pubitemid 128634973)
6. Fujimoto J.G. Optical coherence tomography for ultrahigh resolution in vivo imaging. Nat. Biotechnol. 21, 1361-1367 (2003). (Pubitemid 37356623)
7. Tearney G.J. et al. Three-dimensional coronary artery microscopy by intracoronary optical frequency domain imaging. JACC Cardiovasc. Imaging 1, 752-761 (2008).
8. Takarada S. et al. Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion. Catheter. Cardiovasc. Interv. 75, 202-206 (2010).
9. Jaffer F.A. et al. Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation 118, 1802-1809 (2008).
10. McCarthy J.R. et al. Multimodal nanoagents for the detection of intravascular thrombi. Bioconjug. Chem. 20, 1251-1255 (2009).
11. Ntziachristos V., Bremer C. & Weissleder R. Fluorescence imaging with near-infrared light: New technological advances that enable in vivo molecular imaging. Eur. Radiol. 13, 195-208 (2003). (Pubitemid 36790510)
12. Sanz J. & Fayad Z.A. Imaging of atherosclerotic cardiovascular disease. Nature 451, 953-957 (2008). (Pubitemid 351305938)
13. Jaffer F.A., Libby P. & Weissleder R. Optical and multimodality molecular imaging: Insights into atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29, 1017-1024 (2009).
14. Ryu S.Y., Choi H.Y., Na J., Choi E.S. & Lee B.H. Combined system of optical coherence tomography and fluorescence spectroscopy based on double-cladding fiber. Opt. Lett. 33, 2347-2349 (2008).
15. Yabushita H. et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 106, 1640-1645 (2002).
16. Takano M. et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am. J. Cardiol. 99, 1033-1038 (2007). (Pubitemid 46560470)
17. Kume T. et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am. J. Cardiol. 97, 1713-1717 (2006). (Pubitemid 43817856)
18. Camenzind E., Steg P.G. & Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: A cause for concern. Circulation 115, 1440-1455 discussion 1455 (2007). (Pubitemid 46648381)
19. Holmes D.R. Jr. et al. Stent thrombosis. J. Am. Coll. Cardiol. 56, 1357-1365 (2010).
20. Finn A.V. et al. Vascular responses to drug eluting stents: Importance of delayed healing. Arterioscler. Thromb. Vasc. Biol. 27, 1500-1510 (2007). (Pubitemid 46986103)
21. Guagliumi G. & Sirbu V. Optical coherence tomography: High resolution intravascular imaging to evaluate vascular healing after coronary stenting. Catheter. Cardiovasc. Interv. 72, 237-247 (2008).
22. Chen J. et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation 105, 2766-2771 (2002). (Pubitemid 34615149)
23. Prati F. et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: Physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur. Heart J. 31, 401-415 (2010).
24. Terashima M. et al. Accuracy and reproducibility of stent-strut thickness determined by optical coherence tomography. J. Invasive Cardiol. 21, 602-605 (2009).
25. Gonzalo N. et al. Reproducibility of quantitative optical coherence tomography for stent analysis. EuroIntervention 5, 224-232 (2009).
26. de Boer O.J., van der Wal A.C., Teeling P. & Becker A.E. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: A prominent role for neovascularization? Cardiovasc. Res. 41, 443-449 (1999). (Pubitemid 29087340)